| The Chelsea Collection Inc. (CLSN) Bringing 'G-H-3-PLUS' Famous European Anti-Aging Treatment to Ame |
|
|
|
| Tuesday, 01 November 2005 | |
The Chelsea Collection Inc. (CLSN) Bringing 'G-H-3-PLUS' Famous European Anti-Aging Treatment to AmericaLAS VEGAS, NV, (NAMC) - The Chelsea Collection Inc. (Pink Sheets: CLSN) announced that it has the trademark and formula rights to G-H-3-PLUS anti-aging treatment. G-H-3-PLUS therapy enables the body to maintain its biochemical equilibrium and repair with greater ease. G-H-3-PLUS therapy inhibits the aging process by extending the lives of our cells. G-H-3-PLUS therapy will be offered in clinics throughout the United States and Canada. Negotiations for licensing agreements are under way. This treatment was founded by Dr. Ana Aslan in 1956 and has been offered in Romania for several years. Studies have been conducted worldwide, with more than 800 performed in the United States at such prestigious institutions as Harvard Medical School, New York Medical College, and Duke University Medical Center. Flo Ternes, president/CEO, said, "It is exciting to be part of the G-H-3-PLUS therapy. We are anticipating offering the treatment at our first clinic in the first quarter of 2006." A number of statements contained in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development, and market acceptance conditions, successful integration of acquisitions and the ability to secure additional sources of financing. The actual results that CLSN may achieve could differ materially from any forward-looking statements due to such risks and uncertainties. Contact: |
